We aim to leverage your business with data driven actionable insights and smart business decisions
Our approach allows for shorter time-to-market for new cannabis-based medical and pharma developments, according to FDA guidelines and regulations.
Designing and deploying quality systems and GMP initiatives
Facilitating medical device development process with reliability predictions and performance analysis
Facilitating new drug development process with bioinformatics models and computer simulations
Providing full support for your pre-clinical clinical trials
Implementing a systematic approach for development of drug products and drug manufacturing processes
We identify nutritional and functional values for food manufacturers and retailers
We conduct experiments and clinical trials to discover and promote new insights and knowledge regarding the benefits of cannabis
Research findings and insights are incorporated into our products:
1. Risk management platform
2. Cannabis growing AI platform
Cannytix, an Israeli based technology and R&D company was founded with a mission to deliver and promote new standards and processes for the cannabis ecosystem.
Our uniqueness is our proven ability to transform real-time data into significant business edge by using analytical models and cutting edge technologies.
Cannytix team, led by Prof. Ron Kenett, has proven track record of providing analytical solutions for leading industries spanning from pharma, medical, food and retail.
A senior data scientist with over 20 years of experience in the application of data analytics, risk
management, organizational processes, dashboard design and implementation and integrated measurement systems in a variety of industries including Biomed and Aerospace.Former President of the European Network for Business and Industrial Statistics (ENBIS) and of the Israel Statistical Association (ISA).
Over 15 years of experience in consulting management teams and facilitating data analysis
paradigms as part of the organizational decision making process. Ariel has extensive knowledge in practical statistics and analytics models as well as background in all product management aspects
Extensive background is in the investment and funds management market with over 15
years of experience of managing investments in mutual funds and provident funds. Alon has extensive expertise in risk management, as well as practical background in technical analysis, statistical analysis, business development and marketing.
Chairman of the KPA Group , Research Professor at the Mathematics Department of the
Visiting Professor at the Institute for Drug Research of the Hebrew University in Jerusalem. He is an applied statistician who made recognized contributions to statistical methods and data science applications in a range of areas including biostatistics, design of experiments, statistical process control and risk management.
Former President of the European Network for Business and Industrial Statistics (ENBIS) and of the Israel Statistical Association (ISA).
Dr. Yoed Kenett holds a Phd: Gonda Multidisciplinary Brain Research Center at Bar-Ilan University .
a postdoctoral fellow at the Department of Psychology at the University of Pennsylvania.
Dr. Kenett applies state-of-the-art methods to study the complexity of creative thinking, and how it varies across typical and clinical populations. Specifically, he studies the role of knowledge in generating and evaluating creative ideas.
Entrepreneur, CEO and director of private and public high-tech companies and venture capital.
Over 20 years’ experience in team management and leading high end technological solutions.
Co-founder in several ventures, handling all technical aspects of the projects from bootstrap to large scaled operation,and computational neuroscienceFormer President of the European Network for Business and Industrial Statistics (ENBIS) and of the Israel Statistical Association (ISA).
Scientific consultant for foodtech and wellness startups, registered dietitian, biotechnologist, co-founder and the CSO (chief science officer)